https://orphan-drugs.magnusconferences.com/ 1.0 https://orphan-drugs.magnusconferences.com/program/scientific-sessions 0.9 https://orphan-drugs.magnusconferences.com/about/past-events 0.9 https://orphan-drugs.magnusconferences.com/about/about-organizer 0.9 https://orphan-drugs.magnusconferences.com/about/testimonials-reviews 0.9 https://orphan-drugs.magnusconferences.com/privacy-policy 0.9 https://orphan-drugs.magnusconferences.com/terms-and-conditions 0.9 https://orphan-drugs.magnusconferences.com/scientific-committee/2023 0.8 https://orphan-drugs.magnusconferences.com/speakers/2023 2026-01-21 0.8 https://orphan-drugs.magnusconferences.com/speaker/roy-g-beran 0.8 https://orphan-drugs.magnusconferences.com/speaker/sergey-suchkov 0.8 https://orphan-drugs.magnusconferences.com/speaker/daniel-scherman 0.8 https://orphan-drugs.magnusconferences.com/speaker/wang-huaixiu 0.8 https://orphan-drugs.magnusconferences.com/speaker/jiao-fuyong 0.8 https://orphan-drugs.magnusconferences.com/speaker/fereshteh-sedaghat 0.8 https://orphan-drugs.magnusconferences.com/speaker/magali-taiel 0.8 https://orphan-drugs.magnusconferences.com/speaker/j-somasekar 0.8 https://orphan-drugs.magnusconferences.com/speaker/angel-cuesta 0.8 https://orphan-drugs.magnusconferences.com/speaker/kondakova-o-b 0.8 https://orphan-drugs.magnusconferences.com/speaker/kranthi-kumar-singamaneni 0.8 https://orphan-drugs.magnusconferences.com/speaker/priyanka-wadhwa 0.8 https://orphan-drugs.magnusconferences.com/speaker/arti-sharma 0.8 https://orphan-drugs.magnusconferences.com/speaker/zeynep-unluturk 0.8 https://orphan-drugs.magnusconferences.com/speaker/vicki-ratner 0.8 https://orphan-drugs.magnusconferences.com/speaker/paul-l-kaufman 0.8 https://orphan-drugs.magnusconferences.com/speaker/harsha-rajasimha 0.8 https://orphan-drugs.magnusconferences.com/speaker/daniel-wainstock 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023 2024-03-22 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/precision-pharmacotherapy-in-the-treatment-of-epilepsy-use-of-antiseizure-medications-and-therapeutic-blood-level-monitoring 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/personalized-and-precision-medicine-ppm-as-a-unique-healthcare-model-to-be-set-up-through-biodesign-driven-and-inspired-biotech-translational-applications-and-upgraded-business-marketing-to-secure-the-human-healthcare-wellness-and-biosafety 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/the-foundation-for-rare-disease-and-its-role-in-the-european-rare-disease-research-landscape 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/what-does-a-technology-enabled-patient-concierge-mean-to-the-orphan-drugs-industry 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/progress-related-in-genetic-research-on-kawasaki-disease 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/covid-19-seems-to-be-initiated-by-the-heparan-sulfate-dysregulation-by-coronavirus-the-use-of-low-molecular-weight-heparin-lmwh-can-prevent-and-treat-covid-19-when-it-is-used-in-early-stages-as-a-heparan-sulfate-regulating-medicine 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/lumevoq-gene-therapy-in-leber-hereditary-optic-neuropathy 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/drug-recommendation-system-using-a-collaborative-filtering-in-machine-learning 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/blockers-of-2-adrenergic-receptors-reduce-inflammation-and-oxidative-stress-in-von-hippel-lindau-rare-tumor 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/rare-forms-of-primary-enzyme-defects-in-monoamine-biosynthesis-aadcd-and-th-deficient-progressive-infantile-encephalopathy 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/cyber-security-role-for-rare-diseases-and-pharmaceutical-industry 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/unlocking-hope-indias-initiatives-to-improve-rare-disease-healthcare 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/immunoproteomic-approach-towards-vaccine-development-against-botulism-of-c-botulinum-type-b 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/neiman-pick-disease-type-c-early-onset-dementia 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/interstitial-cystitis-bladder-pain-syndrome-a-rare-disease 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/gene-and-stem-cell-therapy-for-glaucoma 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/the-effect-of-eupalinolide-b-on-amyotrophic-lateral-sclerosis-a-case-report 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-program/2023/advancing-rare-disease-policy-in-latin-america-a-call-to-action 0.8 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/molecular-genetic-etiology 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/medical-aspects-and-regulatory-issues 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/genetics-and-epigenetics 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/rare-case-studies-and-reports 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/orphan-drugs-clinical-research 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/global-rare-diseases-and-orphan-drug-market 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/health-policies-and-services-organization 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/prevalence-epidemiology-and-forecasting 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/pharmacology-and-toxicology 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/genomics-and-proteomics-of-rare-disease 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/gene-and-stem-cell-therapy 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/post-marketing-safety-and-treatment-outcomes 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/clinical-research-and-developments 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/drug-discovery-and-developments 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/translational-science 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/molecular-genetics 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/medical-affairs-and-regulatory-affairs 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/access-and-pricing 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/rare-genetic-diseases-disorders 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/biomedical-research-and-rare-diseases 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/orphan-drug-therapeutics 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/transforming-care-for-rare-diseases 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/revolutionary-changes 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/diagnosis-and-challenges 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/advancing-research-for-rare-diseases 0.9 https://orphan-drugs.magnusconferences.com/program/scientific-sessions/rare-diseases-and-ultra-rare-diseases 0.9 https://orphan-drugs.magnusconferences.com/uploads/pdfs/initial-announcement.pdf 0.8 https://orphan-drugs.magnusconferences.com/uploads/pdfs/final-program.pdf 0.8 https://orphan-drugs.magnusconferences.com/uploads/pdfs/conference-brochure.pdf 0.8 https://orphan-drugs.magnusconferences.com/uploads/pdfs/sponsors-exhibitors.pdf 0.8 https://orphan-drugs.magnusconferences.com/uploads/pdfs/abstract-submission-sample.docx 0.8 https://orphan-drugs.magnusconferences.com/2023 0.8 https://orphan-drugs.magnusconferences.com/uploads/past-events/international-conference-on-orphan-drugs-and-rare-diseases-2023-book.pdf 0.8 https://orphan-drugs.magnusconferences.com/uploads/past-events/international-conference-on-orphan-drugs-and-rare-diseases-2023-program.pdf 0.8 https://orphan-drugs.magnusconferences.com/gallery 0.8 https://orphan-drugs.magnusconferences.com/gallery/cancer-conference-2018 0.8 https://orphan-drugs.magnusconferences.com/gallery/cancer-conference-2016 0.8 https://orphan-drugs.magnusconferences.com/gallery/nursing-conference-2017 0.8 https://orphan-drugs.magnusconferences.com/gallery/nursing-conference-2018 0.8